Drug safety update: Loperamide (Imodium): reports of serious cardiac adverse reactions with high doses of loperamide associated with abuse or misuse

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update following reports of cardiac events including QT prolongation, torsades de pointes, and cardiac arrest in
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news